Search tips
Search criteria 


Logo of brmedjLink to Publisher's site
Br Med J. 1960 August 13; 2(5197): 485–491.
PMCID: PMC2097108

Genetic Control of Isoniazid Metabolism in Man

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • ARMSTRONG AR, PEART HE. A comparison between the behavior of Eskimos and non-Eskimos to the administration of isoniazid. Am Rev Respir Dis. 1960 Apr;81:588–594. [PubMed]
  • BARCLAY WR, EBERT RH, LE ROY GV, MANTHEI RW, ROTH LJ. Distribution and excretion of radioactive isoniazid in tuberculous patients. J Am Med Assoc. 1953 Apr 18;151(16):1384–1388. [PubMed]
  • BELL JC, RIEMENSNIDER DK, MITCHELL RS. Effect of certain aromatic amines on serum isoniazid concentrations in tuberculous patients. Am Rev Tuberc. 1957 Jul;76(1):152–158. [PubMed]
  • BERTE SJ, LEIFHEIT HC, DEWLETT HJ, TUCKER EB. A critical analysis of the accuracy of a chemical and biologic method of determining serum free isoniazid. Am Rev Tuberc. 1959 Mar;79(3):344–350. [PubMed]
  • BONICKE R, REIF W. Enzymatische Inaktivierung von Isonicotinsäurehydrazid im menschlichen und tierischen Organismus. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1953;220(4):321–323. [PubMed]
  • DORMER BA, HARRISON I, SWART JA, VIDOR SR. Prophylactic isoniazid: protection of infants in a tuberculosis hospital. Lancet. 1959 Nov 21;2(7108):902–903. [PubMed]
  • DRABKIN DL. Imperfection: biochemical phobias and metabolic ambivalence. Perspect Biol Med. 1959;2(4):473–517. [PubMed]
  • ELMENDORF DF, Jr, CAWTHON WU, MUSCHENHEIM C, McDERMOTT W. The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man. Am Rev Tuberc. 1952 Apr;65(4):429–442. [PubMed]
  • GRUNBERG E, LEIWANT B, D'ASCENSIO IL, SCHNITZER RJ. On the lasting protective effect of hydrazine derivatives of isonicotinic acid in the experimental tuberculosis infection of mice. Dis Chest. 1952 Apr;21(4):369–377. [PubMed]
  • HARRIS HW, KNIGHT RA, SELIN MJ. Comparison of isoniazid concentrations in the blood of people of Japanese and European descent; therapeutic and genetic implications. Am Rev Tuberc. 1958 Dec;78(6):944–948. [PubMed]
  • HUGHES HB. On the metabolic fate of isoniazid. J Pharmacol Exp Ther. 1953 Dec;109(4):444–452. [PubMed]
  • HUGHES HB, BIEHL JP, JONES AP, SCHMIDT LH. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. Am Rev Tuberc. 1954 Aug;70(2):266–273. [PubMed]
  • MAHER JR, WHITNEY JM, CHAMBERS JS, STANONIS DJ. The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids. Am Rev Tuberc. 1957 Nov;76(5):852–861. [PubMed]
  • ROBITZEK EH, SELIKOFF IJ, ORNSTEIN GG. Chemotherapy of human tuberculosis with hydrazine derivatives of isonicotinic acid; preliminary report of representative cases. Q Bull Sea View Hosp. 1952 Jan;13(1):27–51. [PubMed]
  • SELIKOFF IJ, ROBITZEK EH. Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest. 1952 Apr;21(4):385–438. [PubMed]
  • Stern C. THE HARDY-WEINBERG LAW. Science. 1943 Feb 5;97(2510):137–138. [PubMed]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group